These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23727087)

  • 21. Dramatic reductions in plaque volumes on maximum statin therapy.
    Cardiovasc J Afr; 2011; 22(6):344-5. PubMed ID: 22159326
    [No Abstract]   [Full Text] [Related]  

  • 22. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 23. An echo-guided case report of rapid regression of unstable mobile thrombus aortic atheroma after aggressive statin and antiplatelet combination therapy.
    Dʼaloia A; Vizzardi E; Caretta G; Zanini G; Bugatti S; Curnis A; Dei Cas L
    Am J Ther; 2014; 21(2):e61-5. PubMed ID: 23817345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who benefits from statins? Patient or focal plaque?
    Fujii K; Masuyama T
    Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract]   [Full Text] [Related]  

  • 28. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
    Hoogeveen RM; Verweij SL; Kaiser Y; Kroon J; Verberne HJ; Vogt L; Moens SJB; Stroes ESG
    Sci Rep; 2021 Feb; 11(1):4126. PubMed ID: 33602971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not.
    Mintz GS
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):378-9. PubMed ID: 24448226
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging.
    Kawahara T; Nishikawa M; Furusawa T; Inazu T; Suzuki G
    J Atheroscler Thromb; 2011; 18(5):384-95. PubMed ID: 21282896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
    Stegman B; Puri R; Cho L; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nissen SE; Nicholls SJ
    Diabetes Care; 2014 Nov; 37(11):3114-20. PubMed ID: 25190674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials.
    Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T
    Int J Cardiol; 2012 Aug; 159(1):69-72. PubMed ID: 22575629
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors underlying regression of coronary atheroma with potent statin therapy.
    Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.
    Krasinski A; Chiu B; Spence JD; Fenster A; Parraga G
    Ultrasound Med Biol; 2009 Nov; 35(11):1763-72. PubMed ID: 19647921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
    Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it?
    Villines TC
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):261-3. PubMed ID: 22421170
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular disease: aortic plaque--dual therapy for a heterogeneous disease.
    King A
    Nat Rev Cardiol; 2013 Jul; 10(7):366. PubMed ID: 23712101
    [No Abstract]   [Full Text] [Related]  

  • 40. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
    Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
    J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.